Sinopharm Group Co (HK:1099) has released an update.
Sinopharm Group Co. Ltd. has released its preliminary financial results for the first half of 2024, revealing a slight decrease in revenue and a notable decline in profits compared to the same period last year. Despite a 1.57% dip in revenue and a decrease in operating and total profits by over 25%, the company’s total assets increased by 8.06%, and net assets per share saw a marginal growth.
For further insights into HK:1099 stock, check out TipRanks’ Stock Analysis page.
